Begin main content

Open Calls for Patient Input

This page lists Common Drug Review (CDR) drug applications received by CADTH and the deadlines for filing patient group input for each drug. For more information about how to provide input, please visit the CDR Patient Input page

Stelara (ustekinumab )

Indications: Ulcerative colitis

Call For Patient Input: July 12, 2019

Patient Input Closed: September 3, 2019

TBC (glucagon)

Indications: Severe hypoglycemic reactions

Call For Patient Input: June 25, 2019

Patient Input Closed: August 15, 2019

Ilumya (tildrakizumab )

Indications: Psoriasis, moderate to severe plaque

Call For Patient Input: June 11, 2019

Patient Input Closed: July 31, 2019

TBC (tafamidis)

Indications: transthyretin-mediated amyloidosis

Call For Patient Input: June 5, 2019

Patient Input Closed: July 25, 2019

TBC (upadacitinib )

Indications: Arthritis, Rheumatoid

Call For Patient Input: May 31, 2019

Patient Input Closed: July 22, 2019

Monoferric (Iron (III) Isomaltoside 1000)

Indications: iron deficiency anemia

Call For Patient Input: May 29, 2019

Patient Input Closed: July 18, 2019